MEDZ Stock Overview
A medical device company, develops, manufactures, and sells implant solutions worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Medartis Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 52.50 |
| 52 Week High | CHF 90.00 |
| 52 Week Low | CHF 45.50 |
| Beta | 0.96 |
| 1 Month Change | 2.54% |
| 3 Month Change | -5.75% |
| 1 Year Change | -31.01% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -57.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -3.6% | -2.3% | -2.2% |
| 1Y | -31.0% | -10.6% | 2.4% |
Return vs Industry: MEDZ underperformed the UK Medical Equipment industry which returned -10.6% over the past year.
Return vs Market: MEDZ underperformed the UK Market which returned 2.4% over the past year.
Price Volatility
| MEDZ volatility | |
|---|---|
| MEDZ Average Weekly Movement | 7.4% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: MEDZ's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: MEDZ's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 860 | Matthias Schupp | www.medartis.com |
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.
Medartis Holding AG Fundamentals Summary
| MEDZ fundamental statistics | |
|---|---|
| Market cap | CHF 727.36m |
| Earnings (TTM) | CHF 4.03m |
| Revenue (TTM) | CHF 220.28m |
180.4x
P/E Ratio3.3x
P/S RatioIs MEDZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDZ income statement (TTM) | |
|---|---|
| Revenue | CHF 220.28m |
| Cost of Revenue | CHF 42.89m |
| Gross Profit | CHF 177.40m |
| Other Expenses | CHF 173.36m |
| Earnings | CHF 4.03m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 18, 2025
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 80.53% |
| Net Profit Margin | 1.83% |
| Debt/Equity Ratio | 2.6% |
How did MEDZ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 22:00 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medartis Holding AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Le Berrigaud | Bryan Garnier & Co |
| Hugo Solvet | Bryan Garnier & Co |
| Christoph Gretler | Credit Suisse |